FDA drops case against Whoop's blood-pressure feature after yearlong battle
Summary
Whoop faced a yearlong regulatory battle over its blood-pressure feature, and the FDA has now dropped the case. The outcome removes a major compliance overhang for the company and lets it continue to position the feature in the market. This kind of regulatory resolution matters for health-tech vendors because it can shape product planning, clinical claims, and approval strategies. It also signals that wearable software features tied to health measurement remain sensitive areas for oversight.
Classifications
industries
No industries detected
applications
Accounting and Taxes
AI Classifications
Labels
Developer Tools
API Management
Health Tech Software
Linked Companies
WHOOP
$10M to $25M